146 related articles for article (PubMed ID: 34746042)
1. Adenocarcinoma with Mixed Subtypes in the Early and Advanced Gastric Cancer.
Zhao X; Li Y; Yang Z; Zhang H; Wang H; Lin J; Liu J; Zhao Q
Can J Gastroenterol Hepatol; 2021; 2021():8497305. PubMed ID: 34746042
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer.
Sheng H; Wei X; Mao M; He J; Luo T; Lu S; Zhou L; Huang Z; Yang A
BMC Cancer; 2019 Nov; 19(1):1071. PubMed ID: 31703713
[TBL] [Abstract][Full Text] [Related]
3. Nomograms to Predict Overall and Cancer-Specific Survival in Gastric Signet-Ring Cell Carcinoma.
Chen CL; Xue DX; Chen HH; Liang MZ; Lin DZ; Yu M; Chen JX; Wu WL
J Surg Res; 2021 Oct; 266():13-26. PubMed ID: 33979736
[TBL] [Abstract][Full Text] [Related]
4. Operable gastric adenocarcinoma with different histological subtypes: Cancer-specific survival in the United States.
Lin CL; Zhu GW; Huang YJ; Zheng W; Yang SG; Ye JX
Saudi J Gastroenterol; 2020; 26(1):46-52. PubMed ID: 32031158
[TBL] [Abstract][Full Text] [Related]
5. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
Wu X; Lin H; Li S
BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and prognostic factors of patients with T3/T4 colorectal signet ring cell carcinoma: a population-based study.
Zhang F; Xu B; Peng Y; Mao Z
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9747-9756. PubMed ID: 37245170
[TBL] [Abstract][Full Text] [Related]
7. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors and Prognosis of T4a Gastric Cancer: A Population-Based Study.
Hu Z; Zuo Z; Miao H; Ning Z; Deng Y
Front Med (Lausanne); 2021; 8():767904. PubMed ID: 35071261
[No Abstract] [Full Text] [Related]
10. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
[TBL] [Abstract][Full Text] [Related]
11. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
13. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
[TBL] [Abstract][Full Text] [Related]
14. Prediction of lymph node metastasis in early gastric signet-ring cell carcinoma: A real-world retrospective cohort study.
Yang JJ; Wang XY; Ma R; Chen MH; Zhang GX; Li X
World J Gastroenterol; 2023 Jun; 29(24):3807-3824. PubMed ID: 37426318
[TBL] [Abstract][Full Text] [Related]
15. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
[TBL] [Abstract][Full Text] [Related]
16. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
17. Incidence and survival of adenocarcinoma with mixed subtypes in patients with colorectal cancer.
Zhang F; Xu B; Peng Y; Mao Z; Tong S
Int J Colorectal Dis; 2023 Aug; 38(1):215. PubMed ID: 37584871
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of a prognostic nomogram for postoperative patients with gastric cardia adenocarcinoma: A study based on the Surveillance, Epidemiology, and End Results database and a Chinese cohort.
Wang L; Ge J; Feng L; Wang Z; Wang W; Han H; Qin Y
Cancer Med; 2023 Jun; 12(12):13111-13122. PubMed ID: 37132269
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
[TBL] [Abstract][Full Text] [Related]
20. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
Front Public Health; 2022; 10():946299. PubMed ID: 36159305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
